MedTrace Logo

The Oxford Risk Factors And Non-Invasive Imaging Study

NCT05169333 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250000

Last updated 2024-12-11

No results posted yet for this study

Summary

ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.

Conditions

Sponsors & Collaborators

  • Caristo Diagnostics Limited

    collaborator INDUSTRY

  • Oxford University Hospitals NHS Trust

    collaborator OTHER

  • British Heart Foundation

    collaborator OTHER

  • Innovate UK

    collaborator OTHER_GOV

  • European Commission

    collaborator OTHER

  • National Consortium of Intelligent Medical Imaging

    collaborator UNKNOWN

  • University of Oxford

    lead OTHER

Principal Investigators

  • Antoniades · University of Oxford

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-23
Primary Completion
2030-02-28
Completion
2030-02-28

Countries

  • United States
  • Australia
  • Belgium
  • China
  • France
  • Germany
  • Greece
  • Hungary
  • Italy
  • Japan
  • Netherlands
  • Romania
  • South Korea
  • United Arab Emirates
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05169333 on ClinicalTrials.gov